Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEG-Intron Maintenance in Multiple Myeloma
NCT01325896Phase 2Unknown
- Sponsor
- Fundación de Investigación Biomédica del Hospital Universitario de La Princesa
- Start
- Sep 2002
- Primary completion
- Mar 2012
- Modality
- Polymer-based Nanoparticles, Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of peginterferon alfa-2b in multiple myeloma (MM), sponsored by Fundación de Investigación Biomédica del Hospital Universitario de La Princesa. Status: unknown.
02
Drugs
peginterferon alfa-2b
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01325896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01325896.